番茄社区

Oncology/Hematology

News, opinions and meeting coverage in oncology/hematology.

NCCN Refines MM Treatment Guidelines

'An attempt to help the clinician make better decisions,' expert says

Gyn Cancer Research Gets Short Shrift in Funding

Mortality-adjusted analysis shows huge disparity versus other cancers

NCCN: Don't Let HIV Status Dictate Cancer Treatment

New guidelines focus on most common cancers in HIV-infected patients

Possible Chlamydia Link with Ovarian Cancer

Associations seen in two separate cohorts of women

Make the Diagnosis: Itchy Fingers from IV Therapy?

Case Findings: A 48-year-old woman who was receiving IV immunoglobulin therapy complained to her doctor that over the past few weeks small vesicles had formed along the sides of her fingers. Some had ruptured and become scaly papules. Her fingers were extremely pruritic, and she said it was "driving her crazy." Can you diagnose the patient?

Two Agents Equal as Pretreatment for Adrenal Tumor Surgery

Phenoxybenzamine, doxazosin OK for perioperative hemodynamic control during PCC resection

New Clues to CAR T-Cell Failure

Chemo effects, T cell energy sources

High Suicide Rate in Urologic Ca Patients

Four to five times higher in British study

HPV Screening Results Changed Depending on Test Used

Could change follow-up recommendations

Steroids and Asthma; One-Time PSA: It's PodMed Double T!

This week's topics include the dangers of e-cigarettes, steroids and asthma, five types of diabetes, and a single PSA measurement and outcomes.

Morning Break: Breast Cancer-Schizophrenia Link; FDA on Essure; Rx for Hearing Loss?

Health news and commentary from around the Web gathered by the 番茄社区 staff

CIN2 Regression Rates Underestimated

Active surveillance better than excision for some patients

Reintervention Rates High for Sacral Neuromodulation

Researchers report 'alarming' rates within 5 years of placement, and urge a device registry

ACS: E-Cigarettes OK for Smoking Cessation ... with Caveats

Short period of dual use OK, if goal is to quit

Gene Expression Test Impacts Melanoma Management

Test assessed high-risk patients based on biological data from 31 genes in tumor tissue

AAD 2018: Emphasis on 'Adult' Education, Engagement

More hands-on sessions, direct participant involvement

Survival Bump in Bladder Cancer with Keytruda

But no outcome advantage for Tecentriq in metastatic urothelial cancer

Time to Metastasis Prolonged in Castration-Resistant Prostate Ca

Researchers found a 22-month improvement with enzalutamide

Apalutamide Slows Metastasis in Prostate Cancer

Two-year delay in metastatic progression with apalutamide

Tranexamic Acid Immediately After Vaginal Delivery Cuts Risk of PPH

Higher rates of nausea/vomiting, but not severe adverse events

Combo Therapy Doubles PFS in Unresectable HCC

Chemoembolization plus sorafenib tops embolization alone

Immunotherapy Combo Active in High-Risk CRC

Disease control in 80% with nivolumab-ipilimumab

Extensive Lavage No Help in Gastric Cancer

Survival outcomes not improved with intraperitoneal treatment

Small PFS Bump in Gastric/GEJ Cancer

Clinical vs statistical significance in trial of first-line ramucirumab

A Patient's Journey: And Now, a Word from a Pathologist

Howard Wolinsky goes one-on-one with pathologist and blogger Lester Raff, MD

Lomustine Price Up 15-Fold After Acquisition by Startup (The Independent)

Is NextSource Pharma the next Turing?

Gladiator Blood and Liquid Gold: Good for What Ails You?

A new book by Lydia Kang, MD, reviews the most dubious cures in history

A Patient's Journey: There's a Vitamin for That

Howard Wolinsky may have the most expensive urine in Chicago

Mixed Results with Regimens for Older AML Patients

Positive data with venetoclax, liposomal cytarabine-daunorubicin

Longer PFS in Myeloma with Add-On Daratumumab

Anti-CD38 drug boosts response to VMP regimen

Freezing Metastatic Lung Tumors Feasible

Provides low morbidity alternative

Lung Biopsies for Genetic Info Appear Safe

Low rate of complications, no deaths

Weather Not a Factor in Pneumothorax Risk with Lung Biopsy

No relationship seen between complications and atmospheric conditions

A Patient's Journey: What Is 'Just Right'?

In this installment of A Patient's Journey, Howard Wolinsky talks A1C with his primary care physician

ACR Poster Roundup: Novel OA Tx; Cancer and RA Biologics

Selections from late-breaker poster presentations at rheumatology meeting

mRCC Agents: Similar Outcomes in Cross-Trial Comparison

PFS, OS not that different between axitinib and cabozantinib

Stool Bacteria May Influence Tx Response in RCC

Also, antibiotic use just before treatment may impact disease progression

Kidney Cancer Patients Take to Twitter for Support, Info

Social media platform may be useful for trial recruitment, researchers say

Insurance Status Linked to mRCC Survival Odds

Patients with private insurance get better treatment, have better outcomes

Shared Decision-Making Strategies for Lung Ca Screening Get High Marks

Patient satisfaction high with physician-led and web-based approaches

鈥�

65

鈥�